aluates Reports

$ 0.0

Automative

Peanut Allergy Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-4F7283

Global Peanut Allergy Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Peanut Allergy Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-4F7283

Report

September 2024

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Allergy Therapeutics

Aravax

Immunomic Therapeutic

Astellas

Aimmune

Peanut Allergy Vaccine - Market Size

The global market for Peanut Allergy Vaccine was estimated to be worth US$ 678 million in 2023 and is forecast to a readjusted size of US$ 6097.5 million by 2030 with a CAGR of 37.4% during the forecast period 2024-2030

Peanut Allergy Vaccine - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Peanut Allergy Vaccine by region & country, by Type, and by Application.

The Peanut Allergy Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Vaccine.

Market Segmentation

Scope of Peanut Allergy Vaccine - Market Report

Report Metric	Details
Report Name	Peanut Allergy Vaccine - Market
Forecasted market size in 2030	US$ 6097.5 million
CAGR	37.4%
Forecasted years	2024 - 2030
Segment by Type:	ASP0892 AR101 Others
Segment by Application	Hospitals Personal Clinics Government Agencies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergy Therapeutics, Aravax, Immunomic Therapeutic, Astellas, Aimmune
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Peanut Allergy Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Peanut Allergy Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Peanut Allergy Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Peanut Allergy Vaccine - Market size in 2030?

Ans: The Peanut Allergy Vaccine - Market size in 2030 will be US$ 6097.5 million.

Who are the main players in the Peanut Allergy Vaccine - Market report?

Ans: The main players in the Peanut Allergy Vaccine - Market are Allergy Therapeutics, Aravax, Immunomic Therapeutic, Astellas, Aimmune

What are the Application segmentation covered in the Peanut Allergy Vaccine - Market report?

Ans: The Applications covered in the Peanut Allergy Vaccine - Market report are Hospitals, Personal Clinics, Government Agencies, Others

What are the Type segmentation covered in the Peanut Allergy Vaccine - Market report?

Ans: The Types covered in the Peanut Allergy Vaccine - Market report are ASP0892, AR101, Others

1 Market Overview

1.1 Peanut Allergy Vaccine Product Introduction

1.2 Global Peanut Allergy Vaccine Market Size Forecast

1.2.1 Global Peanut Allergy Vaccine Sales Value (2019-2030)

1.2.2 Global Peanut Allergy Vaccine Sales Volume (2019-2030)

1.2.3 Global Peanut Allergy Vaccine Sales Price (2019-2030)

1.3 Peanut Allergy Vaccine Market Trends & Drivers

1.3.1 Peanut Allergy Vaccine Industry Trends

1.3.2 Peanut Allergy Vaccine Market Drivers & Opportunity

1.3.3 Peanut Allergy Vaccine Market Challenges

1.3.4 Peanut Allergy Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Peanut Allergy Vaccine Players Revenue Ranking (2023)

2.2 Global Peanut Allergy Vaccine Revenue by Company (2019-2024)

2.3 Global Peanut Allergy Vaccine Players Sales Volume Ranking (2023)

2.4 Global Peanut Allergy Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Peanut Allergy Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Peanut Allergy Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Peanut Allergy Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Peanut Allergy Vaccine

2.9 Peanut Allergy Vaccine Market Competitive Analysis

2.9.1 Peanut Allergy Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Peanut Allergy Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peanut Allergy Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 ASP0892

3.1.2 AR101

3.1.3 Others

3.2 Global Peanut Allergy Vaccine Sales Value by Type

3.2.1 Global Peanut Allergy Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Peanut Allergy Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Peanut Allergy Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Peanut Allergy Vaccine Sales Volume by Type

3.3.1 Global Peanut Allergy Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Peanut Allergy Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Peanut Allergy Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Peanut Allergy Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Personal Clinics

4.1.3 Government Agencies

4.1.4 Others

4.2 Global Peanut Allergy Vaccine Sales Value by Application

4.2.1 Global Peanut Allergy Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Peanut Allergy Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Peanut Allergy Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Peanut Allergy Vaccine Sales Volume by Application

4.3.1 Global Peanut Allergy Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Peanut Allergy Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Peanut Allergy Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Peanut Allergy Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Peanut Allergy Vaccine Sales Value by Region

5.1.1 Global Peanut Allergy Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Peanut Allergy Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Peanut Allergy Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Peanut Allergy Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Peanut Allergy Vaccine Sales Volume by Region

5.2.1 Global Peanut Allergy Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Peanut Allergy Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Peanut Allergy Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Peanut Allergy Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Peanut Allergy Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Peanut Allergy Vaccine Sales Value, 2019-2030

5.4.2 North America Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Peanut Allergy Vaccine Sales Value, 2019-2030

5.5.2 Europe Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Peanut Allergy Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Peanut Allergy Vaccine Sales Value, 2019-2030

5.7.2 South America Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Peanut Allergy Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Peanut Allergy Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Peanut Allergy Vaccine Sales Value

6.2.1 Key Countries/Regions Peanut Allergy Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Peanut Allergy Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Peanut Allergy Vaccine Sales Value, 2019-2030

6.3.2 United States Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Peanut Allergy Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Peanut Allergy Vaccine Sales Value, 2019-2030

6.4.2 Europe Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Peanut Allergy Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Peanut Allergy Vaccine Sales Value, 2019-2030

6.5.2 China Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Peanut Allergy Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Peanut Allergy Vaccine Sales Value, 2019-2030

6.6.2 Japan Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Peanut Allergy Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Peanut Allergy Vaccine Sales Value, 2019-2030

6.7.2 South Korea Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Peanut Allergy Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Peanut Allergy Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Peanut Allergy Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Peanut Allergy Vaccine Sales Value, 2019-2030

6.9.2 India Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Peanut Allergy Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Allergy Therapeutics

7.1.1 Allergy Therapeutics Company Information

7.1.2 Allergy Therapeutics Introduction and Business Overview

7.1.3 Allergy Therapeutics Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Allergy Therapeutics Peanut Allergy Vaccine Product Offerings

7.1.5 Allergy Therapeutics Recent Development

7.2 Aravax

7.2.1 Aravax Company Information

7.2.2 Aravax Introduction and Business Overview

7.2.3 Aravax Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Aravax Peanut Allergy Vaccine Product Offerings

7.2.5 Aravax Recent Development

7.3 Immunomic Therapeutic

7.3.1 Immunomic Therapeutic Company Information

7.3.2 Immunomic Therapeutic Introduction and Business Overview

7.3.3 Immunomic Therapeutic Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Immunomic Therapeutic Peanut Allergy Vaccine Product Offerings

7.3.5 Immunomic Therapeutic Recent Development

7.4 Astellas

7.4.1 Astellas Company Information

7.4.2 Astellas Introduction and Business Overview

7.4.3 Astellas Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Astellas Peanut Allergy Vaccine Product Offerings

7.4.5 Astellas Recent Development

7.5 Aimmune

7.5.1 Aimmune Company Information

7.5.2 Aimmune Introduction and Business Overview

7.5.3 Aimmune Peanut Allergy Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Aimmune Peanut Allergy Vaccine Product Offerings

7.5.5 Aimmune Recent Development

8 Industry Chain Analysis

8.1 Peanut Allergy Vaccine Industrial Chain

8.2 Peanut Allergy Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Peanut Allergy Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Peanut Allergy Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Allergy Therapeutics

Aravax

Immunomic Therapeutic

Astellas

Aimmune

List of Tables

Table 1. Peanut Allergy Vaccine Market Trends

Table 2. Peanut Allergy Vaccine Market Drivers & Opportunity

Table 3. Peanut Allergy Vaccine Market Challenges

Table 4. Peanut Allergy Vaccine Market Restraints

Table 5. Global Peanut Allergy Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Peanut Allergy Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Peanut Allergy Vaccine Sales Volume by Company (2019-2024) & (K Doses)

Table 8. Global Peanut Allergy Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Peanut Allergy Vaccine Price by Company (2019-2024) & (USD/Dose)

Table 10. Key Manufacturers Peanut Allergy Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Peanut Allergy Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Peanut Allergy Vaccine

Table 13. Global Peanut Allergy Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peanut Allergy Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Peanut Allergy Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Peanut Allergy Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Peanut Allergy Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Peanut Allergy Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Peanut Allergy Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Peanut Allergy Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)

Table 22. Global Peanut Allergy Vaccine Sales Volume by Type (2019-2024) & (K Doses)

Table 23. Global Peanut Allergy Vaccine Sales Volume by Type (2025-2030) & (K Doses)

Table 24. Global Peanut Allergy Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Peanut Allergy Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Peanut Allergy Vaccine Price by Type (2019-2024) & (USD/Dose)

Table 27. Global Peanut Allergy Vaccine Price by Type (2025-2030) & (USD/Dose)

Table 28. Global Peanut Allergy Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Peanut Allergy Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Peanut Allergy Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Peanut Allergy Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Peanut Allergy Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Peanut Allergy Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)

Table 34. Global Peanut Allergy Vaccine Sales Volume by Application (2019-2024) & (K Doses)

Table 35. Global Peanut Allergy Vaccine Sales Volume by Application (2025-2030) & (K Doses)

Table 36. Global Peanut Allergy Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Peanut Allergy Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Peanut Allergy Vaccine Price by Application (2019-2024) & (USD/Dose)

Table 39. Global Peanut Allergy Vaccine Price by Application (2025-2030) & (USD/Dose)

Table 40. Global Peanut Allergy Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Peanut Allergy Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Peanut Allergy Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Peanut Allergy Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Peanut Allergy Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Peanut Allergy Vaccine Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030

Table 46. Global Peanut Allergy Vaccine Sales Volume by Region (2019-2024) & (K Doses)

Table 47. Global Peanut Allergy Vaccine Sales Volume by Region (2025-2030) & (K Doses)

Table 48. Global Peanut Allergy Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Peanut Allergy Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Peanut Allergy Vaccine Average Price by Region (2019-2024) & (USD/Dose)

Table 51. Global Peanut Allergy Vaccine Average Price by Region (2025-2030) & (USD/Dose)

Table 52. Key Countries/Regions Peanut Allergy Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Peanut Allergy Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Peanut Allergy Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Peanut Allergy Vaccine Sales Volume, (2019-2024) & (K Doses)

Table 56. Key Countries/Regions Peanut Allergy Vaccine Sales Volume, (2025-2030) & (K Doses)

Table 57. Allergy Therapeutics Company Information

Table 58. Allergy Therapeutics Introduction and Business Overview

Table 59. Allergy Therapeutics Peanut Allergy Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 60. Allergy Therapeutics Peanut Allergy Vaccine Product Offerings

Table 61. Allergy Therapeutics Recent Development

Table 62. Aravax Company Information

Table 63. Aravax Introduction and Business Overview

Table 64. Aravax Peanut Allergy Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 65. Aravax Peanut Allergy Vaccine Product Offerings

Table 66. Aravax Recent Development

Table 67. Immunomic Therapeutic Company Information

Table 68. Immunomic Therapeutic Introduction and Business Overview

Table 69. Immunomic Therapeutic Peanut Allergy Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 70. Immunomic Therapeutic Peanut Allergy Vaccine Product Offerings

Table 71. Immunomic Therapeutic Recent Development

Table 72. Astellas Company Information

Table 73. Astellas Introduction and Business Overview

Table 74. Astellas Peanut Allergy Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 75. Astellas Peanut Allergy Vaccine Product Offerings

Table 76. Astellas Recent Development

Table 77. Aimmune Company Information

Table 78. Aimmune Introduction and Business Overview

Table 79. Aimmune Peanut Allergy Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 80. Aimmune Peanut Allergy Vaccine Product Offerings

Table 81. Aimmune Recent Development

Table 82. Key Raw Materials Lists

Table 83. Raw Materials Key Suppliers Lists

Table 84. Peanut Allergy Vaccine Downstream Customers

Table 85. Peanut Allergy Vaccine Distributors List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Peanut Allergy Vaccine Product Picture

Figure 2. Global Peanut Allergy Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Peanut Allergy Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Peanut Allergy Vaccine Sales Volume (2019-2030) & (K Doses)

Figure 5. Global Peanut Allergy Vaccine Sales Price (2019-2030) & (USD/Dose)

Figure 6. Peanut Allergy Vaccine Report Years Considered

Figure 7. Global Peanut Allergy Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Peanut Allergy Vaccine Players Sales Volume Ranking (2023) & (K Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Peanut Allergy Vaccine Revenue in 2023

Figure 10. Peanut Allergy Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. ASP0892 Picture

Figure 12. AR101 Picture

Figure 13. Others Picture

Figure 14. Global Peanut Allergy Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Peanut Allergy Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Peanut Allergy Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)

Figure 17. Global Peanut Allergy Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Peanut Allergy Vaccine Price by Type (2019-2030) & (USD/Dose)

Figure 19. Product Picture of Hospitals

Figure 20. Product Picture of Personal Clinics

Figure 21. Product Picture of Government Agencies

Figure 22. Product Picture of Others

Figure 23. Global Peanut Allergy Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Peanut Allergy Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Peanut Allergy Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)

Figure 26. Global Peanut Allergy Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Peanut Allergy Vaccine Price by Application (2019-2030) & (USD/Dose)

Figure 28. North America Peanut Allergy Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Peanut Allergy Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Peanut Allergy Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Peanut Allergy Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Peanut Allergy Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Peanut Allergy Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Peanut Allergy Vaccine Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Peanut Allergy Vaccine Sales Volume (%), (2019-2030)

Figure 40. United States Peanut Allergy Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Peanut Allergy Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Peanut Allergy Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Peanut Allergy Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. China Peanut Allergy Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. China Peanut Allergy Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Peanut Allergy Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Peanut Allergy Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Peanut Allergy Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Peanut Allergy Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Peanut Allergy Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Peanut Allergy Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. India Peanut Allergy Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Peanut Allergy Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 60. India Peanut Allergy Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 61. Peanut Allergy Vaccine Industrial Chain

Figure 62. Peanut Allergy Vaccine Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions